Forxiga tablets are indicated as a once daily oral medication to improve glycaemic control in adult patients with type 2 diabetes mellitus.

AstraZeneca Pharma MD Sanjay Murdeshwar said the drug will offer an additional treatment option to over 63 million diabetes mellitus patients in India.

"Forxiga represents a significant advancement in the treatment of type 2 diabetes mellitus with global safety and efficacy data of four years," he added.

The pharma company had received the approval of Drug Controller General of India in February. The drug is currently approved in 40 countries, it mentioned. Shares of AstraZeneca surged 20 percent to Rs 1,147.70 in the morning trade on BSE today.

Latest News  from Business News Desk